193 related articles for article (PubMed ID: 2193365)
1. [Physiology of the portal system and physiopathology of portal hypertension].
Lebrec D
Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
[TBL] [Abstract][Full Text] [Related]
2. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
3. Splanchnic hemodynamics in idiopathic portal hypertension: comparison with chronic persistent hepatitis.
Ohnishi K; Sato S; Nomura F; Iida S
Am J Gastroenterol; 1989 Apr; 84(4):403-8. PubMed ID: 2929561
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of portal hypertension].
Montaño-Loza A; Meza-Junco J
Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of portal hypertension.
Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic portal hypertension and its pathology.
Okudaira M; Ohbu M; Okuda K
Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
[TBL] [Abstract][Full Text] [Related]
10. Portal hypertension: state of the art.
Gatta A; Sacerdoti D; Bolognesi M; Merkel C
Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
[TBL] [Abstract][Full Text] [Related]
11. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic and progressive increase of portal venous pressure on renal handling of water and electrolytes in rats.
Blanchart A; Fernández-Muñoz D; Caramelo C; Hernando L; López-Novoa JM
Miner Electrolyte Metab; 1985; 11(5):295-300. PubMed ID: 3900673
[TBL] [Abstract][Full Text] [Related]
13. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
14. Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistula.
Wattanasirichaigoon S; Gordon FD; Resnick RH
Med Hypotheses; 2000 Jul; 55(1):77-87. PubMed ID: 11021333
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of liver circulation with an overview of medical and invasive treatments.
Bombardieri G; Conti LR
Rays; 1997; 22(2):196-210. PubMed ID: 9351328
[TBL] [Abstract][Full Text] [Related]
16. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
[TBL] [Abstract][Full Text] [Related]
17. [Experimental observation of high portal venous resistance in dogs].
Wang WM
Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):349-51, 381. PubMed ID: 8258105
[TBL] [Abstract][Full Text] [Related]
18. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
Shah V
J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
[TBL] [Abstract][Full Text] [Related]
20. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
